David M. Marks, MD
- 6Articles
- 22.2KReads
- 2008–2015Active
- 14Collaborators
- 24Citations
About
David M. Marks, MD, has published extensively on topics including neurology, somatoform disorders, anxiety, anxiolytics, cognition, and major depressive disorder. His work encompasses clinical studies on the use of milnacipran for chronic pain conditions such as fibromyalgia and radicular pain, as well as investigations into pharmacologic treatments for depression and anxiety disorders. Marks's research includes clinical trials assessing the effects of medications like escitalopram and paroxetine in various psychiatric and somatic conditions.
Publications
Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review
September 17, 2015
A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease
August 15, 2014
Open-Label Milnacipran for Patients With Persistent Knee Pain 1 Year or Longer After Total Knee Arthroplasty: A Pilot Study
July 11, 2013
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
